4basebio UK Societas stock forecast
Want to see GB:4BB full AI Analyst Report?
4basebio UK Societas (4BB) Share Forecast & Price Target
4BB Analyst Ratings
4BB Stock 12 Month Forecast
Average Price Target
1,000.00 p▲(90.48% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Charles Weston | RBC Capital | 1,000 p | buy | 90.48%Upside | Reiterated | 09/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Charles WestonRBC Capital | BuyReiterated1,000 p | 09/28/26 | 90.48%Upside |
Best Analysts Covering 4basebio UK Societas
Copying Charles Weston's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -11.98% per trade.
Copying Charles Weston's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -28.78% per trade.
Copying Charles Weston's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -28.88% per trade.
4BB Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 1 | 1 |
In the current month, 4BB has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4BB average Analyst price target in the past 3 months is 1,000.00.
4BB Financial Forecast
4BB Earnings Forecast
Next quarter’s earnings estimate for 4BB is -GBX 0.60 with a range of -GBX 0.60 to -GBX 0.60. The previous quarter’s EPS was -GBX 0.58. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
4BB Sales Forecast
Next quarter’s sales forecast for 4BB is GBX 788.00K with a range of GBX 788.00K to GBX 788.00K. The previous quarter’s sales results were GBX 262.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

